Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Spotlight Innovation has finalized plans for entering into an agreement with Maitland Labs, based in Orlando, Florida, to establish its drug production and product development facilities at Maitland Lab’s sterile fill drug production plant, currently under construction.
Subscribe to our email newsletter
The facility is scheduled to be operational in September 2016, and will be FDA registered and compliant with Good Manufacturing Practice standards.
Spotlight Innovation will also use the facility to produce product for use in pre-clinical testing and for its clinical trials.
Paul Reid, PhD, Spotlight Innovation’s Director of Product Development, said, "As we continue to move forward with our pre-clinical and clinical trials, the opportunity to be based in a state-of-the-art, first-in-class processing facility will offer us consistency and greater efficiency in the production and delivery of clinical samples, and future manufacturing capability."
Spotlight Innovation identifies and acquires rights to innovative and proprietary platform technology candidates with a focus on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and unique opportunities